概括
研究人员克隆了人类的衰变加速因子 (DAF),一种补充级联抑制剂. 发现两个DAF mRNA变异表明,这种重要的免疫调节蛋白的膜结合和分泌形式都被产生.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 衰变加速因子 (DAF) 是一种细胞膜糖蛋白,通过结合C3b和C4b来抑制补充级联放大.
- DAF在保护宿主细胞膜免受补充介导损伤方面发挥着至关重要的作用.
研究的目的:
- 报告人类DAF的分子克隆.
- 为了研究潜在的DAF异型的分子基础.
主要方法:
- 从HeLa细胞中克隆人类DAF的分子.
- 对DAF互补DNA (cDNA) 序列的分析.
- 对DAF信使RNA (mRNA) 拼接变体的检查.
- 对表达数据进行分析,以支持mRNA翻译.
主要成果:
- 确定了两个不同的类别的人类DAF mRNA,不同的拼接事件.
- 这种拼接事件引入了一个编码移,导致两个潜在的DAF蛋白具有不同的C端域.
- 主要的拼接mRNA (90%) 可能编码与膜结合的DAF,而小的未拼接mRNA (10%) 可能编码分泌的形式.
- 这两种mRNA变体都在多体体上发现,这表明这两种形式的翻译.
- 推断的DAF序列揭示了四个重复单元,它们是蛋白质重复的补充.
结论:
- 人类DAF存在至少两种形式,潜在的膜结合和分泌,由替代mRNA拼接产生的.
- 这些发现为DAF在免疫系统中的调节和功能提供了洞察力.
- 结构同质性表明DAF属于更广泛的补充调节蛋白家族.
相关概念视频
RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
RACE - Rapid Amplification of cDNA Ends
Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific primer.
Since the...
Since the...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.


